These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 16739868)
1. Anticardiolipin antibodies, recurrent stroke and vascular events: a prospective study on 210 patients. Tănăsescu R; Ticmeanu M; Nicolau A; Uscătescu V; Cojocaru M; Grecu V; Serbănescu A Rom J Intern Med; 2005; 43(1-2):79-88. PubMed ID: 16739868 [TBL] [Abstract][Full Text] [Related]
2. High prevalence of anticardiolipin antibodies in patients with asymptomatic hepatitis C virus infection associated acute ischemic stroke. Cojocaru IM; Cojocaru M; Iacob SA Rom J Intern Med; 2005; 43(1-2):89-95. PubMed ID: 16739869 [TBL] [Abstract][Full Text] [Related]
3. Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke? van Goor MP; Alblas CL; Leebeek FW; Koudstaal PJ; Dippel DW Acta Neurol Scand; 2004 Jun; 109(6):410-5. PubMed ID: 15147465 [TBL] [Abstract][Full Text] [Related]
4. Anticardiolipin-antibodies in stroke and in other neurological disorders. Perju-Dumbrava L; Zeiler K; Kapiotis S; Deecke L Rom J Neurol Psychiatry; 1995; 33(2):137-43. PubMed ID: 7547377 [TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon. Rodriguez VE; Gonzalez-Pares EN; Rivera C P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096 [TBL] [Abstract][Full Text] [Related]
6. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus. Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C Lupus; 2007; 16(10):810-6. PubMed ID: 17895304 [TBL] [Abstract][Full Text] [Related]
7. Detecting anti-prothrombin antibodies in young women with acute ischemic stroke. Cojocaru IM; Cojocaru M; Tănăsescu R; Burcin C; Mitu AC; Iliescu I; Dumitrescu L; Pavel I; Silosi I Rom J Intern Med; 2008; 46(4):337-41. PubMed ID: 19480300 [TBL] [Abstract][Full Text] [Related]
8. [Recurrence and prognosis in ischemic stroke patients with anticardiolipin antibody in Japan]. Kitagawa Y; Shinohara Y; Niwa K; Yoshitoshi M; Kametsu Y Rinsho Shinkeigaku; 1994 Aug; 34(8):799-804. PubMed ID: 7994987 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of antiphospholipid antibodies in young women with ischemic stroke. Cojocaru IM; Cojocaru M; Burcin C; Atanasiu A Rom J Intern Med; 2007; 45(2):201-4. PubMed ID: 18333375 [TBL] [Abstract][Full Text] [Related]
10. Anti-beta(2)-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome. Ali HY; Abdullah ZA J Immunotoxicol; 2008 Apr; 5(2):173-7. PubMed ID: 18569388 [TBL] [Abstract][Full Text] [Related]
11. IgG anti-cardiolipin antibodies-markers of inflammation in diabetic patients with ischemic stroke. Cojocaru IM; Cojocaru M; Muşuroi C; Botezat M Rom J Intern Med; 2003; 41(3):277-81. PubMed ID: 15526511 [TBL] [Abstract][Full Text] [Related]
12. Anticardiolipin antibodies as an independent risk factor for stroke in young Saudis. Daif AK Funct Neurol; 1998; 13(4):285-9. PubMed ID: 9934572 [TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. Levine SR; Brey RL; Tilley BC; Thompson JL; Sacco RL; Sciacca RR; Murphy A; Lu Y; Costigan TM; Rhine C; Levin B; Triplett DA; Mohr JP; JAMA; 2004 Feb; 291(5):576-84. PubMed ID: 14762036 [TBL] [Abstract][Full Text] [Related]
14. [Anticardiolopin antibodies as a risk factor in stroke]. Krześniak-Bohdan M; Dobrzyńska L; Bakowska A; Banecka-Majkutewicz Z Wiad Lek; 1998; 51(9-10):414-8. PubMed ID: 9921104 [TBL] [Abstract][Full Text] [Related]
16. Study of antiphospholipid antibodies in patients treated with antiepileptic drugs. Pardo A; González-Porque P; Gobernado JM; Jiménez-Escrig A; Lousa M Neurologia; 2001 Jan; 16(1):7-10. PubMed ID: 11234666 [TBL] [Abstract][Full Text] [Related]
17. Symptomatic thrombotic events among Egyptian patients with systemic lupus erythematosus: special consideration for renal vein thrombosis. Shahin AA; Mostafa H; Sami H; Shahin HA Z Rheumatol; 2003 Jun; 62(3):246-50. PubMed ID: 12827401 [TBL] [Abstract][Full Text] [Related]
18. The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event. Sebastian JK; Voetsch B; Stone JH; Romay-Penabad Z; Lo GH; Allen NB; Davis JC; Hoffman GS; McCune WJ; St Clair EW; Specks U; Spiera R; Loscalzo J; Pierangeli S; Merkel PA; J Rheumatol; 2007 Dec; 34(12):2446-50. PubMed ID: 17918782 [TBL] [Abstract][Full Text] [Related]
19. High titer of anticardiolipin antibody is associated with first-ever ischemic stroke in Taiwan. Lien LM; Chen WH; Chiu HC; Pan WH; Chen JR; Bai CH Cerebrovasc Dis; 2006; 22(4):225-30. PubMed ID: 16788294 [TBL] [Abstract][Full Text] [Related]
20. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis. Marie I; Jouen F; Hellot MF; Levesque H Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]